"Dry eye disease is one of the most common topics patients discuss when visiting eye care professionals," says Dr. Tom Tooma, founder of NVISION Laser Eye Centers.
Newport Beach, Calif. (PRWEB) February 20, 2013
NVISION Laser Eye Centers today announced that it is one of the first in Southern California to introduce a new treatment for patients who suffer from Evaporative Dry Eye disease. This disease stems from a deficiency in the oily lipid layer of the eye’s natural tear film. The oily lipids serve as a protective layer so that the aqueous (water) layer of the eye’s tear film does not evaporate.
Dry eye disease affects more than 23 million Americans. Of those, 86 percent suffer from Evaporative Dry Eye. Common symptoms of dry eye include dryness, grittiness, soreness, irritation, burning and eye fatigue. These symptoms can hinder people’s daily activities such as reading, using the computer, wearing contact lenses and being outdoors on windy days. Many dry eye patients complain those symptoms worsen throughout the day.
“Dry eye disease is one of the most common topics patients discuss when visiting eye care professionals,” said Dr. Tom Tooma, Founder of NVISION Laser Eye Centers. “We are very pleased to introduce the new LipiFlow treatment to help those patients who are very frustrated with this chronic disease and all of the ways it negatively impacts their lives. In effect, LipiFlow helps the meibomian glands resume their natural function and many patients note symptom relief.”
This new, advanced in-office treatment, called LipiFlow®, is intended to treat patients with blocked meibomian glands, called meibomian gland dysfunction, by unblocking the glands and allowing them to resume the secretion of oily lipids needed for a healthy tear film.
Historically, common therapies aimed at dry eye symptom relief included using warm compresses, over- the-counter wetting drops and ointments, and prescription drugs. Alternatively, the new LipiFlow treatment addresses the root cause of evaporative dry eye by unblocking the meibomian glands that secrete oily lipids. In controlled clinical studies of patients who received a single LipiFlow treatment, the average meibomian gland score at four weeks increased by two to three times over the baseline condition, which reflects improvement in the number of glands secreting and secretion quality. Additionally, at four weeks after the LipiFlow treatment, 79% of patients reported improvement in dry eye symptoms.
About NVISION Laser Eye Centers
NVISION Laser Eye Centers now has 17 locations throughout California. NVISION Laser Eye Centers is the first provider in California to offer LASIK eye surgery with the Swiss-engineered Ziemer Femto LDVD Crystal Line™ Laser -- the highest level of laser vision correction available today. NVISION is also the first provider in California to offer the bladeless, computer-controlled LenSx laser, unquestionably the most technologically advanced option for laser cataract surgery.
With more than 1,400 eye doctors who refer their patients and trust their own eyes to NVISION surgeons, NVISION Laser Eye Centers is the Eye Doctors’ #1 Choice. For more information, visit http://www.NVISIONCenters.com or call 1-877-91NVISION (1-877-916-8474).